Affiliation:
1. Smt. N.M. Padalia Pharmacy College, Sarkhej Changodar Road, Navapura, Ahmedabad-382210, India
Abstract
An innovative sequential step of detecting new medicines or drugs dependent on the information of a
target is called drug design. The drug is a small molecule that alters the capacity of a bimolecular,
example, protein, receptor or catalyst that leads to restorative incentive for patients. Designing of drug
by computational method helped steady use of computational science to find, improve and study drugs
as well as biologically related active molecules. The displaying examines like the structure-based
plan; ligand-based drugs structure; database looking and restricting partiality dependent on the
information of a biological target. In this article, we present the zones where CADD (computer aided
drug design) devices uphold the medication disclosure measure.
Publisher
Asian Journal of Chemistry
Reference42 articles.
1. J.M. Beale and J.H. Wilson, Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, Lippincols Williams & Wilkins, Walters Kluwer Company, Ed.: 10, pp. 43-155 (1998).
2. L. Boruah, A. Das, L.M. Nainwal, N. Agrawal and B. Shankar, In-Silico Drug Design: A Revolutionary Approach to Change the Concept of Current Drug Discovery Process, Indian J. Pharm. Biol. Res., 1, 60 (2013).
3. M.S. Chorghade, Drug Discovery and Development,Wiley Interscience, John Wiley & Sons, Inc., Hoboken, New Jersey, pp. 233-269 (2006).
4. 10.1186/s12935-015-0221-1
5. Reviewing Ligand-Based Rational Drug Design: The Search for an ATP Synthase Inhibitor